As of 2026-04-06, the Intrinsic Value of Anuh Pharma Ltd (506260.BO) is 56.62 INR. This 506260.BO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 73.90 INR, the upside of Anuh Pharma Ltd is -23.40%.
The range of the Intrinsic Value is 47.69 - 70.35 INR
Based on its market price of 73.90 INR and our intrinsic valuation, Anuh Pharma Ltd (506260.BO) is overvalued by 23.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 47.69 - 70.35 | 56.62 | -23.4% |
| DCF (Growth 10y) | 59.93 - 85.69 | 70.23 | -5.0% |
| DCF (EBITDA 5y) | 84.68 - 96.55 | 90.84 | 22.9% |
| DCF (EBITDA 10y) | 85.18 - 105.20 | 94.86 | 28.4% |
| Fair Value | 294.46 - 294.46 | 294.46 | 298.46% |
| P/E | 79.43 - 105.57 | 90.85 | 22.9% |
| EV/EBITDA | 63.03 - 79.46 | 73.37 | -0.7% |
| EPV | 32.25 - 39.79 | 36.02 | -51.3% |
| DDM - Stable | 29.43 - 58.32 | 43.88 | -40.6% |
| DDM - Multi | 49.49 - 75.53 | 59.75 | -19.1% |
| Market Cap (mil) | 7,270.25 |
| Beta | 0.57 |
| Outstanding shares (mil) | 98.38 |
| Enterprise Value (mil) | 7,356.69 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.76% |
| Cost of Debt | 8.93% |
| WACC | 14.74% |